Literature DB >> 29327138

Handling and reporting of transperineal template prostate biopsy in Europe: a web-based survey by the European Network of Uropathology (ENUP).

Solene-Florence Kammerer-Jacquet1,2, Eva Compérat3, Lars Egevad4, Ondra Hes5, Jon Oxley6, Murali Varma7, Glen Kristiansen8, Daniel M Berney9.   

Abstract

Transperineal template prostate biopsies (TTPB) are performed for assessments after unexpected negative transrectal ultrasound biopsies (TRUSB), correlation with imaging findings and during active surveillance. The impact of TTPBs on pathology has not been analysed. The European Network of Uropathology (ENUP) distributed a survey on TTPB, including how specimens were received, processed and analysed. Two hundred forty-four replies were received from 22 countries with TTPBs seen by 68.4% of the responders (n = 167). Biopsies were received in more than 12 pots in 35.2%. The number of cores embedded per cassette varied between 1 (39.5%) and 3 or more (39.5%). Three levels were cut in 48.3%, between 2 and 3 serial sections in 57.2% and unstained spare sections in 45.1%. No statistical difference was observed with TRUSB management. The number of positive cores was always reported and the majority gave extent per core (82.3%), per region (67.1%) and greatest involvement per core (69.4%). Total involvement in the whole series and continuous/discontinuous infiltrates were reported in 42.2 and 45.4%, respectively. The majority (79.4%) reported Gleason score in each site or core, and 59.6% gave an overall score. A minority (28.5%) provided a map or a diagram. For 19%, TTPB had adversely affected laboratory workload with only 27% managing to negotiate extra costs. Most laboratories process samples thoroughly and report TTPB similarly to TRUSB. Although TTPB have caused considerable extra work, it remains uncosted in most centres. Guidance is needed for workload impact and minimum standards of processing if TTPB work continues to increase.

Keywords:  Survey; Transperineal template biopsy; Transrectal ultrasound biopsies; Workload impact

Mesh:

Year:  2018        PMID: 29327138     DOI: 10.1007/s00428-017-2265-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  23 in total

1.  Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillance.

Authors:  Al V Taira; Gregory S Merrick; Abbey Bennett; Hugo Andreini; Walter Taubenslag; Robert W Galbreath; Wayne M Butler; Nathan Bittner; Edward Adamovich
Journal:  Am J Clin Oncol       Date:  2013-04       Impact factor: 2.339

2.  The reasons behind variation in Gleason grading of prostatic biopsies: areas of agreement and misconception among 266 European pathologists.

Authors:  Daniel M Berney; Ferran Algaba; Philippe Camparo; Eva Compérat; David Griffiths; Glen Kristiansen; Antonio Lopez-Beltran; Rodolfo Montironi; Murali Varma; Lars Egevad
Journal:  Histopathology       Date:  2013-11-06       Impact factor: 5.087

Review 3.  Transperineal biopsy of the prostate--is this the future?

Authors:  Dwayne T S Chang; Benjamin Challacombe; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2013-09-24       Impact factor: 14.432

Review 4.  Transperineal template-guided mapping biopsy of the prostate.

Authors:  Arjun Sivaraman; Rafael Sanchez-Salas; Eric Barret; Youness Ahallal; Francois Rozet; Marc Galiano; Dominique Prapotnich; Xavier Cathelineau
Journal:  Int J Urol       Date:  2014-11-25       Impact factor: 3.369

5.  Prostate needle biopsy processing: a survey of laboratory practice across Europe.

Authors:  Murali Varma; Daniel M Berney; Ferran Algaba; Philippe Camparo; Eva Compérat; David F R Griffiths; Glen Kristiansen; Antonio Lopez-Beltran; Rodolfo Montironi; Lars Egevad
Journal:  J Clin Pathol       Date:  2012-10-30       Impact factor: 3.411

6.  Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Authors:  T Van der Kwast; L Bubendorf; C Mazerolles; M R Raspollini; G J Van Leenders; C-G Pihl; P Kujala
Journal:  Virchows Arch       Date:  2013-08-06       Impact factor: 4.064

Review 7.  The role of the multiparametric MRI in the diagnosis of prostate cancer in biopsy-naïve men.

Authors:  Adrian Rhudd; Jean McDonald; Mark Emberton; Veeru Kasivisvanathan
Journal:  Curr Opin Urol       Date:  2017-09       Impact factor: 2.309

8.  Clinical utility of transperineal template-guided mapping biopsy of the prostate after negative magnetic resonance imaging-guided transrectal biopsy.

Authors:  Arjun Sivaraman; Rafael Sanchez-Salas; Hashim U Ahmed; Eric Barret; Nathalie Cathala; Annick Mombet; Facundo Uriburu Pizarro; Arie Carneiro; Steeve Doizi; Marc Galiano; Francois Rozet; Dominique Prapotnich; Xavier Cathelineau
Journal:  Urol Oncol       Date:  2015-05-06       Impact factor: 3.498

9.  Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy.

Authors:  Yasushi Nakai; Nobumichi Tanaka; Satoshi Anai; Makito Miyake; Shunta Hori; Yoshihiro Tatsumi; Yosuke Morizawa; Tomomi Fujii; Noboru Konishi; Kiyohide Fujimoto
Journal:  BMC Urol       Date:  2017-04-05       Impact factor: 2.264

10.  Partial Prostatectomy for Anterior Cancer: Short-term Oncologic and Functional Outcomes.

Authors:  Arnauld Villers; Philippe Puech; Vincent Flamand; Georges-Pascal Haber; Mihir M Desai; Sebastien Crouzet; Xavier Leroy; Sameer Chopra; Laurent Lemaitre; Adil Ouzzane; Inderbir S Gill
Journal:  Eur Urol       Date:  2016-09-06       Impact factor: 20.096

View more
  1 in total

Review 1.  Standardization of reporting discontinuous tumor involvement in prostatic needle biopsy: a systematic review.

Authors:  Min Lu; Shulin Wu; Chin-Lee Wu
Journal:  Virchows Arch       Date:  2021-01-06       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.